| Determining bioequivalence possibilities of long acting injectables through population PK modelling P Gajjar, J Dickinson, H Dickinson, L Ruston, HB Mistry, C Patterson, ... European Journal of Pharmaceutical Sciences 179, 106296, 2022 | 6 | 2022 |
| Model Informed-Development of Amorphous Systems (MI-DAS)-an in-silico polymer selection tool for ASD development E Roberts, S Rahman, S Ahmed, H Dickinson, P Gajjar, T Austin, ... British Journal of Pharmacy 8 (2), 2023 | | 2023 |
| Administration of a psychedelic compound H Dickinson, PA Dickinson, N Parisi US Patent App. 18/196,567, 2023 | | 2023 |
| Population PK modelling as an alternative route to bioequivalence P Gajjar, J Dickinson, H Dickinson, L Ruston, HB Mistry, C Patterson, ... British Journal of Pharmacy 7 (2), S1-S2, 2022 | | 2022 |
| Development of a methodology to enable non-linear in vitro-in vivo correlation for complex long-acting injections\ J Dickinson, C Patterson, P Gajjar, H Dickinson, PA Dickinson preparation, 0 | | |
| British Journal of Pharmacy P Gajjara, J Dickinsona, H Dickinsona, L Rustona, HB Mistrya, ... | | |
